Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam in D-IBS
NCT00911612Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2009
- Primary completion
- May 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of colesevelam in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Mayo Clinic. Started Jan 2009; status: completed.
02
Drugs
colesevelam
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00911612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911612.